NEW YORK, Aug. 21, 2020 (GLOBE NEWSWIRE) — Renalytix AI plc (LSE: RENX) (NASDAQ: RNLX), today announced …
Read More »
COPENHAGEN, Denmark, Aug. 31, 2020 /PRNewswire/ — H. Lundbeck A/S (Lundbeck) today announced headline results …
Read More »
SAN CARLOS, Calif., Sept. 2, 2020 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a pioneer and …
Read More »
Last year, 2016, brought a whirlwind of changes and progress to the hepatitis C field, …
Read More »
HORSHAM, Pa., July 30, 2020 — The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the …
Read More »
REDWOOD CITY, Calif., July 30, 2020 (GLOBE NEWSWIRE) — Guardant Health, Inc. (Nasdaq: GH) today announced …
Read More »
WILMINGTON, Del.–(BUSINESS WIRE)–AstraZeneca’s TAGRISSO® (osimertinib) has been granted Breakthrough Therapy Designation (BTD) in the US for the …
Read More »
BRISBANE, Calif.–(BUSINESS WIRE)–Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that it …
Read More »
CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS WIRE)–Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the U.S. …
Read More »
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, today …
Read More »
BOSTON, July 30, 2020 (GLOBE NEWSWIRE) — IMARA Inc. (Nasdaq: IMRA), a clinical-stage biopharmaceutical company …
Read More »
READING, England–(BUSINESS WIRE)– Detailed results from the positive Phase 2b trial for nirsevimab showed a …
Read More »
PRINCETON, N.J., & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Bristol Myers Squibb (NYSE: BMY) and bluebird bio, Inc. (Nasdaq: BLUE) today …
Read More »
Basel, 29 July 2020 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced US Food …
Read More »
NORTH CHICAGO, Ill., July 29, 2020 /PRNewswire/ — AbbVie (NYSE: ABBV) today announced that the Phase 3 …
Read More »
BRUSSELS, July 29, 2020 /PRNewswire/ — UCB today announced an agreement to enter into a …
Read More »
KENILWORTH, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced …
Read More »
SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: …
Read More »
WILMINGTON, Del.–(BUSINESS WIRE)–High-level results from FARXIGA®’s (dapagliflozin) Phase III DAPA-CKD trial showed a statistically significant …
Read More »
Specialty Pharma Journal Specialty, Precision & Technology
